
Koninklijke Philips N.V. PHG
$ 26.0
2.54%
Quarterly report 2025-Q4
added 05-06-2026
Koninklijke Philips N.V. Operating Cycle 2011-2026 | PHG
Annual Operating Cycle Koninklijke Philips N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 89 | 87.9 | 91.7 | 86.7 | 82.9 | 95 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 95 | 82.9 | 88.9 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
87 | $ 19.86 | 9.48 % | $ 611 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 5.95 | 15.09 % | $ 7.91 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 21.59 | 5.89 % | $ 626 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
128 | $ 134.07 | 5.54 % | $ 16.8 B | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 23.31 | 4.48 % | $ 1.24 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 153.02 | 6.34 % | $ 12 B | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.72 | -1.47 % | $ 7.61 M | ||
|
Illumina
ILMN
|
204 | $ 168.23 | -1.58 % | $ 26.1 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 102.2 | 1.95 % | $ 6.9 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 185.37 | 3.06 % | $ 9.19 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 181.46 | 1.04 % | $ 24.4 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 456.63 | 1.29 % | $ 13.2 B | ||
|
NeoGenomics
NEO
|
102 | $ 11.52 | 13.56 % | $ 1.48 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
48.3 | $ 225.61 | 6.5 % | $ 30.8 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.68 | 3.36 % | $ 440 M | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.74 | 7.61 % | $ 439 M | ||
|
Personalis
PSNL
|
63.8 | $ 12.3 | 14.1 % | $ 1.1 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 7.03 | 4.61 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
204 | $ 2.15 | 1.9 % | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 260.8 | 0.73 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 75.21 | 3.97 % | $ 4.5 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 481.71 | 1.64 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.68 | -2.84 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.12 | 3.52 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 195.86 | 1.13 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
834 | $ 377.42 | -0.62 % | $ 22.5 B |